Cargando…

PSMA PET/CT to evaluate response to SBRT for prostate cancer bone metastases

BACKGROUND: In the current study we evaluated (68)Ga PSMA PET/ CT to measure local control of bone metastasis in oligometastatic prostate cancer patients treated with SBRT. MATERIALS AND METHODS: After the institutional review board approval, a retrospective review of medical records of consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadetski, Igor, Eshet, Yael, Kaidar-Person, Orit, Amit, Uri, Domachevsky, Liran, Davidson, Tima, Weiss, Ilana, Ben Ayun, Maoz, Symon, Zvi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382074/ https://www.ncbi.nlm.nih.gov/pubmed/34434568 http://dx.doi.org/10.5603/RPOR.a2021.0071

Ejemplares similares

The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate Cancer
por: Ben Shimol, Jennifer, et al.
Publicado: (2022)

Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes
por: Lewin, Ron, et al.
Publicado: (2021)

FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study
por: Eifer, Michal, et al.
Publicado: (2022)

Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
por: Eshet, Yael, et al.
Publicado: (2021)

COVID-RO study: the radiation oncology practice at times of COVID-19 outbreak — international survey
por: Appel, Sarit, et al.
Publicado: (2021)

The utility of PET/CT in large vessel vasculitis
por: Ben Shimol, Jennifer, et al.
Publicado: (2020)

Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer
por: Gadot, Moran, et al.
Publicado: (2020)

COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake
por: Eifer, Michal, et al.
Publicado: (2022)

Penile secondary lesions: a rare entity detected by PET/CT
por: Davidson, Tima, et al.
Publicado: (2021)

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer
por: Mohan, Riche, et al.
Publicado: (2023)

Correlation between incidental FDG PET/CT colorectal observations and endoscopic and histopathological results
por: RAINIS, TOVA, et al.
Publicado: (2014)

Pelvic salvage (SBRT) radiotherapy based on (68)Ga-PSMA PET/CT: About a case
por: Slaoui, A., et al.
Publicado: (2019)

Suspected CNS Metastases of Askin's Tumor: Would You Irradiate the Neural Axis?
por: Kaidar-Person, Orit, et al.
Publicado: (2012)

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
por: Amit, Uri, et al.
Publicado: (2019)

Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)

Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
por: Gawish, Ahmed, et al.
Publicado: (2022)

Palliative radiation therapy for symptomatic advance breast cancer
por: Jacobson, Galia, et al.
Publicado: (2021)

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
por: Keidar, Zohar, et al.
Publicado: (2018)

Correction to: Metabolic response after 68 Ga‑PSMA‑PET/CT‑directed IGRT/SBRT for oligometastases prostate cancer
por: Gawish, Ahmed, et al.
Publicado: (2023)

Imaging of COVID-19 Vaccination at FDG PET/CT
por: Eifer, Michal, et al.
Publicado: (2021)

Lymphoepithelioma-Like Carcinoma of the Salivary Gland: Is Radiotherapy Alone Adequate?
por: Kaidar-Person, Orit, et al.
Publicado: (2011)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma
por: Harris, Nathanial, et al.
Publicado: (2023)

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer
por: Pastorello, Edoardo, et al.
Publicado: (2023)

Team Work: Mastectomy, Reconstruction, and Radiation
por: Kaidar-Person, Orit, et al.
Publicado: (2017)

Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates
por: Rosenzweig, Barak, et al.
Publicado: (2022)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
por: Groshar, David, et al.
Publicado: (2017)

Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
por: Saad, Akram, et al.
Publicado: (2017)

Vulvar Cancer in the North of Israel
por: Kaidar-Person, Orit, et al.
Publicado: (2014)

The Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma
por: Kaidar-Person, Orit, et al.
Publicado: (2015)

The clinical application of (68)Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer
por: Pei, Yuchen, et al.
Publicado: (2023)

(68)Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
por: Damjanovic, Jonathan, et al.
Publicado: (2019)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Brain Metastasis of Nasopharyngeal Carcinoma: A Case Report and Literature Review
por: Kaidar-Person, Orit, et al.
Publicado: (2012)

Reexpansion of atelectasis caused by use of continuous positive airway pressure (CPAP) before radiation therapy (RT)
por: Appel, Sarit, et al.
Publicado: (2016)

Application of nanotechnology to cancer radiotherapy
por: Mi, Yu, et al.
Publicado: (2016)

Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients
por: Zur, Inbar, et al.
Publicado: (2020)

18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)
por: Bernstine, Hanna, et al.
Publicado: (2018)

(68)Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer
por: Damjanovic, Jonathan, et al.
Publicado: (2018)

RADI-42. ASSOCIATION BETWEEN TUMOR LOCATION AND TOXICITY OUTCOMES AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
por: Wang, Boya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f7s75lrn2444uhnim8ib6tojco